Chimeric antigen receptor T-cell (CAR T-cell) therapy is a process developed to treat certain forms of cancers, especially blood cancers like leukemia and lymphoma. Recently, however, researchers have started exploring…
Continue Reading
TMA’s Global Myositis Patient Conference – Celebrating Our Worldwide Community!Register Now!
Chimeric antigen receptor T-cell (CAR T-cell) therapy is a process developed to treat certain forms of cancers, especially blood cancers like leukemia and lymphoma. Recently, however, researchers have started exploring…
Continue ReadingTMA was honored to partner with Myositis Support and Understanding (MSU) to host the Externally Led Patient Focused Drug Development (PFDD) meeting for adult dermatomyositis (DM) on June 7. View…
Continue ReadingTMA’s top 10 travel tips help you achieve those bucket-list wishes, including making the most of our International Annual Patient Conference.
Continue ReadingThe first-ever Externally Led Patient Focused Drug Development (EL-PFDD) meeting on June 7 offered a critical way for patients and their family members to highlight what life with DM is like.
Continue ReadingTMA medical advisor and patient advocate Ingrid de Groot insists patients be involved in medical research.
Continue Reading